LifeStance Health Group, Inc. (LFST)

NMS – Real vaqt narxi. Valyuta: USD

10.28

+0.40 (4.05%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

10.35

+0.07 (0.68%)

Bozordan keyin: Jun 26, 2026, 7:17 PM EDT

09.06.2026

4 Outpatient Home Health Stocks Benefiting From Industry Trends

An aging population and rising telehealth and AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, LFST and AVAH stand to benefit.

29.05.2026

Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 37.3% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

26.05.2026

Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now

After losing some value lately, a hammer chart pattern has been formed for LifeStance Health (LFST), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

14.05.2026

LifeStance Health Group, Inc. (LFST) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

13.05.2026

Earnings Estimates Rising for LifeStance Health (LFST): Will It Gain?

LifeStance Health Group (LFST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

13.05.2026

LifeStance Health Group (LFST) is a Great Momentum Stock: Should You Buy?

Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.

13.05.2026

Wall Street Analysts See a 31.02% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?

The consensus price target hints at a 31% upside potential for LifeStance Health (LFST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Videolar

No Data

There is no data to display

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
LFST	Goldman	Neutral	undefined >> $9	June 5th 2026

Press-relizlar

08.05.2026

LifeStance Health Group Announces Pricing of Secondary Public Offering

SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 35,000,000 shares of LifeStance's common stock, par value $0.01 per share (the “Common Stock”) at a public offering price of $8.15 per share, pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”) from certain stockholders of the Company (the “Selling Stockholders”). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering.

07.05.2026

LifeStance Health Group Announces Launch of Secondary Public Offering

SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”), certain stockholders of the Company (the “Selling Stockholders”) intend to offer 35,000,000 shares of LifeStance's common stock, par value $0.01 per share (the “Common Stock”). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering.

07.05.2026

LifeStance Reports First Quarter 2026 Results

SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2026.

09.04.2026

LifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at Scale

Analysis of 180,000 Patients Validates Measurement-Informed Care for Anxiety and Depression SCOTTSDALE, Ariz., April 9, 2026 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of outpatient mental health care, published new clinical outcomes data demonstrating that LifeStance patients treated for anxiety and depression broadly experienced clinically significant improvements in their symptoms.

LifeStance Health Group, Inc. (LFST)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

LifeStance Health Group, Inc. (LFST)

4 Outpatient Home Health Stocks Benefiting From Industry Trends

Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know

Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now

LifeStance Health Group, Inc. (LFST) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

Earnings Estimates Rising for LifeStance Health (LFST): Will It Gain?

LifeStance Health Group (LFST) is a Great Momentum Stock: Should You Buy?

Wall Street Analysts See a 31.02% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

LifeStance Health Group Announces Pricing of Secondary Public Offering

LifeStance Health Group Announces Launch of Secondary Public Offering

LifeStance Reports First Quarter 2026 Results

LifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at Scale

4 Outpatient Home Health Stocks Benefiting From Industry Trends

Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know

Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now

LifeStance Health Group, Inc. (LFST) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

Earnings Estimates Rising for LifeStance Health (LFST): Will It Gain?

LifeStance Health Group (LFST) is a Great Momentum Stock: Should You Buy?

Wall Street Analysts See a 31.02% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

LifeStance Health Group Announces Pricing of Secondary Public Offering

LifeStance Health Group Announces Launch of Secondary Public Offering

LifeStance Reports First Quarter 2026 Results

LifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at Scale

Search stocks

LifeStance Health Group, Inc. (LFST)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

LifeStance Health Group, Inc. (LFST)

4 Outpatient Home Health Stocks Benefiting From Industry Trends

Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know

Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now

LifeStance Health Group, Inc. (LFST) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

Earnings Estimates Rising for LifeStance Health (LFST): Will It Gain?

LifeStance Health Group (LFST) is a Great Momentum Stock: Should You Buy?

Wall Street Analysts See a 31.02% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

LifeStance Health Group Announces Pricing of Secondary Public Offering

LifeStance Health Group Announces Launch of Secondary Public Offering

LifeStance Reports First Quarter 2026 Results

LifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at Scale

4 Outpatient Home Health Stocks Benefiting From Industry Trends

Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know

Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now

LifeStance Health Group, Inc. (LFST) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

Earnings Estimates Rising for LifeStance Health (LFST): Will It Gain?

LifeStance Health Group (LFST) is a Great Momentum Stock: Should You Buy?

Wall Street Analysts See a 31.02% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

LifeStance Health Group Announces Pricing of Secondary Public Offering

LifeStance Health Group Announces Launch of Secondary Public Offering

LifeStance Reports First Quarter 2026 Results

LifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at Scale